Question: Is Malaria a Vector Borne Disease found in Maryland?
Answer: Yes. (From Med-Chi- selected sections) Malaria regularly presents in the central Maryland region, which claims three international airports and an international harbor.
In 2012 Maryland reported 112 cases of malaria (consistent with the more than 100 cases reported each year in Maryland), a 40% increase from five years ago. Baltimore City, Baltimore County, Montgomery County, and Prince Georges County accounted for 88% of the reported cases.
Perhaps difficult to believe in 2014, a century ago, parts of Maryland were endemic for malaria. A malaria map of the United States in 1912 clearly includes parts of southern Maryland and the Eastern Shore. Today, malaria is mostly an imported disease (except for an unusual incident discussed below).
A vector mosquito for transmitting malaria, Anopheles quadrimaculatus, is indigenous to Maryland and remains the most common species in the eastern United States, and thus there remains a constant risk that malaria could be reintroduced. The Maryland Department of Agriculture conducts surveillance for mosquitoes.
Although trapping is done late May through October for surveillance and also in response to complaints and to assess need for spraying, trapped mosquitoes are not routinely tested for malaria.
In August 2002 Plasmodium vivax malaria was diagnosed in two teenagers in Loudoun County, Virginia, who lived one half mile apart. One patient visited friends directly across the street from the second patient. The area was about 7 miles north of Dulles airport. (Anopheles mosquitoes typically have a range of less than 1 mile.) Neither person had traveled outside the United States or had risk factors for malaria. Both patients were treated and recovered.
In September, mosquito traps were placed in response to complaints of nuisance mosquitoes. The traps captured two Anopheles quadrimaculatus female pools in Loudoun County, and one female Anopheles punctipennis in Fairfax County, each of which tested positive for P. vivax.
In response, additional mosquito traps were set in the general area. Two Anopheles quadrimaculatus female pools collected in Montgomery County tested positive for P. vivax. The Montgomery county testing site was on Selden Island, which lies in the Potomac River between Maryland and Virginia.
At the time the island was privately owned and used primarily as a sod farm for grass. None of the employees of the farm were found to have symptoms or malaria.
The CDC deemed the cases to be locally acquired. More information from Med-Chi, Maryland Medicine, HERE.
Malaria causes symptoms that typically include fever, fatigue, vomiting and headaches. In severe cases it can cause yellow skin, seizures, coma or death. These symptom usually begin ten to fifteen days after being bitten.
In those who have not been appropriately treated disease may recur months later.
The classic symptom of malaria is paroxysm—a cyclical occurrence of sudden coldness followed by shivering and then fever and sweating, occurring every two days (tertian fever) in P. vivax andP. ovale infections, and every three days (quartan fever) for P. malariae. P. falciparum infection can cause recurrent fever every 36–48 hours or a less pronounced and almost continuous fever.
Severe malaria is usually caused by P. falciparum (often referred to as falciparum malaria). Symptoms of falciparum malaria arise 9–30 days after infection.
Individuals with cerebral malaria frequently exhibit neurological symptoms, including abnormal posturing, nystagmus, conjugate gaze palsy (failure of the eyes to turn together in the same direction), opisthotonus, seizures, or coma.
Possible causes include respiratory compensation of metabolic acidosis, noncardiogenic pulmonary oedema, concomitant pneumonia, and severe anaemia. Although rare in young children with severe malaria,acute respiratory distress syndrome occurs in 5–25% of adults and up to 29% of pregnant women.
Infection with P. falciparum may result in cerebral malaria, a form of severe malaria that involves encephalopathy. It is associated with retinal whitening, which may be a useful clinical sign in distinguishing malaria from other causes of fever.
Symptoms of malaria can recur after varying symptom-free periods. Depending upon the cause, recurrence can be classified as either recrudescence, relapse, or reinfection. Recrudescence is when symptoms return after a symptom-free period.
It is caused by parasites surviving in the blood as a result of inadequate or ineffective treatment.
Relapse is when symptoms reappear after the parasites have been eliminated from blood but persist as dormant hypnozoites in liver cells. Relapse commonly occurs between 8–24 weeks and is commonly seen with P. vivax and P. ovale infections.
Reinfection means the parasite that caused the past infection was eliminated from the body but a new parasite was introduced.
Reinfection cannot readily be distinguished from recrudescence, although recurrence of infection within two weeks of treatment for the initial infection is typically attributed to treatment failure. People may develop some immunity when exposed to frequent infections.
Owing to the non-specific nature of the presentation of symptoms, diagnosis of malaria in non-endemic areas requires a high degree of suspicion, which might be elicited by any of the following: recent travel history, enlarged spleen, fever, low number of platelets in the blood, and higher-than-normal levels of bilirubin in the blood combined with a normal level of white blood cells.
Malaria is usually confirmed by the microscopic examination of blood films or by antigen-based rapid diagnostic tests (RDT). Microscopy is the most commonly used method to detect the malarial parasite—about 165 million blood films were examined for malaria in 2010.
Despite its widespread usage, diagnosis by microscopy suffers from two main drawbacks: many settings (especially rural) are not equipped to perform the test, and the accuracy of the results depends on both the skill of the person examining the blood film and the levels of the parasite in the blood.
The sensitivity of blood films ranges from 75–90% in optimum conditions, to as low as 50%. Commercially available RDTs are often more accurate than blood films at predicting the presence of malaria parasites, but they are widely variable in diagnostic sensitivity and specificity depending on manufacturer, and are unable to tell how many parasites are present.
In regions where laboratory tests are readily available, malaria should be suspected, and tested for, in any unwell person who has been in an area where malaria is endemic. In areas that cannot afford laboratory diagnostic tests, it has become common to use only a history of fever as the indication to treat for malaria—thus the common teaching "fever equals malaria unless proven otherwise".
A drawback of this practice is overdiagnosis of malaria and mismanagement of non-malarial fever, which wastes limited resources, erodes confidence in the health care system, and contributes to drug resistance.
Several medications are available to prevent malaria in travellers to areas where the disease is common. Occasional doses of the medication sulfadoxine/ pyrimethamineare recommended in infants and after the first trimester of pregnancy in areas with high rates of malaria. Despite a need, no effective vaccine exists, although efforts to develop one are ongoing.
The recommended treatment for malaria is a combination of antimalarial medications that includes an artemisinin. The second medication may be either mefloquine, lumefantrine, or sulfadoxine/pyrimethamine. Quinine along with doxycycline may be used if an artemisinin is not available.
It is recommended that in areas where the disease is common, malaria is confirmed if possible before treatment is started due to concerns of increasing drug resistance. Resistance has developed to several antimalarial medications; for example, chloroquine-resistant P. falciparum has spread to most malarial areas, and resistance to artemisinin has become a problem in some parts of Southeast Asia.
Malaria is treated with antimalarial medications; the ones used depends on the type and severity of the disease. While medications against fever are commonly used, their effects on outcomes are not clear.
Uncomplicated malaria may be treated with oral medications. The most effective treatment for P. falciparum infection is the use of artemisininsin combination with other antimalarials (known as artemisinin-combination therapy, or ACT), which decreases resistance to any single drug component.
These additional antimalarials include: amodiaquine, lumefantrine, mefloquine or sulfadoxine/pyrimethamine. Another recommended combination is dihydroartemisinin and piperaquine. ACT is about 90% effective when used to treat uncomplicated malaria.
To treat malaria during pregnancy, the WHO recommends the use of quinine plus clindamycin early in the pregnancy (1st trimester), and ACT in later stages (2nd and 3rd trimesters). In the 2000s (decade), malaria with partial resistance to artemisins emerged in Southeast Asia.
Infection with P. vivax, P. ovale or P. malariae is usually treated without the need for hospitalization. Treatment of P. vivax requires both treatment of blood stages (with chloroquine or ACT) as well as clearance of liver forms with primaquine.
Recommended treatment for severe malaria is the intravenous use of antimalarial drugs. For severe malaria, artesunate is superior to quinine in both children and adults. Treatment of severe malaria involves supportive measures that are best done in a critical care unit.
More Information from Wiki: http://en.wikipedia.org/wiki/Malaria
Last Updated- April 2019